- Home
- PDLB vs STRO Comparison
PDLB vs STRO Comparison
Compare PDLB & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- STRO
- Stock Information
- Founded
- PDLB 1960
- STRO 2003
- Country
- PDLB United States
- STRO United States
- Employees
- PDLB N/A
- STRO N/A
- Industry
- PDLB
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PDLB
- STRO Health Care
- Exchange
- PDLB Nasdaq
- STRO Nasdaq
- Market Cap
- PDLB 316.6M
- STRO 77.7M
- IPO Year
- PDLB 2017
- STRO 2018
- Fundamental
- Price
- PDLB $14.25
- STRO $0.76
- Analyst Decision
- PDLB
- STRO Hold
- Analyst Count
- PDLB 0
- STRO 7
- Target Price
- PDLB N/A
- STRO $3.97
- AVG Volume (30 Days)
- PDLB 41.5K
- STRO 1.4M
- Earning Date
- PDLB 07-29-2025
- STRO 08-12-2025
- Dividend Yield
- PDLB N/A
- STRO N/A
- EPS Growth
- PDLB 148.96
- STRO N/A
- EPS
- PDLB 0.60
- STRO N/A
- Revenue
- PDLB $86,682,000.00
- STRO $66,434,000.00
- Revenue This Year
- PDLB $10.97
- STRO N/A
- Revenue Next Year
- PDLB $8.59
- STRO N/A
- P/E Ratio
- PDLB $23.46
- STRO N/A
- Revenue Growth
- PDLB 18.40
- STRO N/A
- 52 Week Low
- PDLB $9.01
- STRO $0.52
- 52 Week High
- PDLB $14.32
- STRO $5.17
- Technical
- Relative Strength Index (RSI)
- PDLB 67.00
- STRO 44.98
- Support Level
- PDLB $13.76
- STRO $0.67
- Resistance Level
- PDLB $14.32
- STRO $0.87
- Average True Range (ATR)
- PDLB 0.29
- STRO 0.08
- MACD
- PDLB 0.10
- STRO -0.01
- Stochastic Oscillator
- PDLB 95.36
- STRO 34.81
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.